Intel to buy back Apollo's 49% stake in Ireland fab for $14.2 billion
Get Alerts APO Hot Sheet
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 2.6%
EPS Growth %: +14.6%
Join SI Premium – FREE
Intel Corporation (NASDAQ: INTC) announced a definitive agreement to repurchase Apollo's (NYSE: APO) 49% equity interest in the joint venture related to Intel's Fab 34 facility in Ireland for $14.2 billion.
Apollo-managed funds acquired the 49% stake in 2024 through an $11.2 billion investment in the joint venture entity. The original transaction provided Intel with equity-like capital while maintaining balance sheet strength.
Intel plans to fund the repurchase through cash on hand and approximately $6.5 billion in new debt proceeds. The company expects the transaction to be accretive to ongoing earnings per share while strengthening its credit profile in 2027 and beyond.
"Our 2024 agreement was the right structure at the right time and provided Intel with meaningful flexibility, enabling us to accelerate critical initiatives," said David Zinsner, Intel CFO. "Today, we have a stronger balance sheet, improved financial discipline and an evolved business strategy."
Apollo Partner Jamshid Ehsani said the partnership began at an important stage in Intel's manufacturing roadmap execution, where Apollo's capital played a role in accelerating next-generation chip technology production.
Fab 34 operates as a high-volume semiconductor fabrication facility for products using Intel 4 and Intel 3 process technologies, including Intel Core Ultra and Intel Xeon 6 processors. Intel continues making capital investments in its Ireland campus to expand manufacturing capacity.
Goldman Sachs served as exclusive financial advisor to Intel, while Morgan Stanley advised the seller's independent board. The transaction details were disclosed in a company statement.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Morgan Stanley upgrades CDW on stronger AI-driven server demand
- Supermicro expands edge AI lineup with new Intel-powered systems
- Simulations Plus uses Nvidia BioNeMo toolkit for drug development AI
Create E-mail Alert Related Categories
Corporate News, Hot Corp. News, Hot M&A, Mergers and AcquisitionsRelated Entities
Goldman Sachs, Morgan Stanley, Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share